Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

LMH Health is adding innovative procedures that could make a big difference for cardiac patients in our community. From the ...

Heart disease remains the leading cause of death for women in the United States, yet awareness of cardiovascular ...

The Department of Medicine at University of Calgary led an analysis comparing several clinical mental disorders with risk of acute coronary syndrome, a term that includes heart attack and emergency ...

Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...

Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation ...

A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...

Heart failure management includes the four pillars (quad therapy) in HFrEF and HFpEF, plus advances in heart transplantation and gene editing.

A major global review has revealed critical gaps in how heart attacks in women are diagnosed and treated—particularly for premenopausal women. The American Heart Association (AHA) today released a new ...

Two types of implantable cardioverter defibrillators can reduce the risk of sudden cardiac death with HCM. Pacemakers and implantable loop recorders also may be options.